Innorna: Engineering Targeted mRNA-LNPs to Advance In Vivo Immunotherapy

  • Introducing Innorna: Company overview, pipeline programs, and platform technologies
  • Case study: Advancing in vivo immunotherapy through targeted mRNA-LNP engineering
  • Exploring opportunities with Innorna’s pipeline and platform across diverse therapeutic areas

NEW DATA